Lucentis (ranibizumab) is a brand-name eye injection that’s prescribed for certain eye conditions in adults. As with other drugs, Lucentis can cause side effects, such as eye pain or irritation.

Additionally, in both studies, significantly more patients who received Lucentis compared with sham injections: Experienced improvements in average eye chart reading scores starting at seven days ...

Lucentis (ranibizumab) is a prescription drug that’s used for eye conditions such as macular edema. Lucentis comes as a liquid solution that’s given by injection into the eye. Lucentis is ...

Ranibizumab, more commonly known by its brand name Lucentis, is delivered as an injection to the eye and runs about $2,023 per dose. Many patients require up to 12 injections per year. That's why ...

Researchers have shown that ranibizumab (Lucentis) eye injections, often in combination with laser treatment, result in better vision than laser treatment alone for diabetes-associated swelling of ...

is just about as effective at treating an eye disease that can lead to blindness as the more commonly used and more expensive Lucentis. Full publication of results from the head-to-head study of ...

A new study, led by Dr. Daniel Martin, an ophthalmologist at the Cleveland Clinic’s Cole Eye Institute, has found that the cancer drug Avastin delivers the same benefits of the drug Lucentis ...

Outlook Therapeutics’ eye disease drug has failed to match Roche’s Lucentis in a key trial. The biotech brushed off the failure, noting positive details and vowing to seek FDA approval ...

Ranibizumab (Lucentis) / bevacizumab (Avastin): Both of ... They can include traumatic cataract, detached retina, increased ...

National Center for Biotechnical Information: “Photodynamic Therapy for The Eye.” FDA: “Avastin (bevacizumab) Information,” “Highlights of Prescribing Information (Lucentis).” ...